Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation

IF 8.6 1区医学 Q1 DERMATOLOGY American Journal of Clinical Dermatology Pub Date : 2023-08-19 DOI:10.1007/s40257-023-00813-4

Andrea Chiricozzi, Michela Ortoncelli, Donatella Schena, Niccolò Gori, Silvia Mariel Ferrucci, Graziella Babino, Maddalena Napolitano, Maria Concetta Fargnoli, Luca Stingeni, Mariateresa Rossi, Marco Romanelli, Riccardo Balestri, Michele Pellegrino, Aurora Parodi, Alberto Maria Bertoldi, Giovanni Palazzo, Flaminia Antonelli, Annalisa Pitino, Giovanni Tripepi, Gabriella Fabbrocini, Anna Balato, Angelo Valerio Marzano, Giampiero Girolomoni, Simone Ribero, Ketty Peris

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

更正：乌帕达西替尼在现实环境中治疗特应性皮炎的长期有效性和安全性：48周观察的中期分析。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

American Journal of Clinical Dermatology 医学-皮肤病学

CiteScore

15.20

自引率

2.70%

发文量

审稿时长

>12 weeks

期刊介绍： The American Journal of Clinical Dermatology is dedicated to evidence-based therapy and effective patient management in dermatology. It publishes critical review articles and clinically focused original research covering comprehensive aspects of dermatological conditions. The journal enhances visibility and educational value through features like Key Points summaries, plain language summaries, and various digital elements, ensuring accessibility and depth for a diverse readership.